DeutschNewstral
Article
Mmarketwatch.com on 2020-07-06 13:59
Emergent BioSolutions inks coronavirus vaccine manufacturing deal with J&J
Related news
Emergent BioSolutions calls J&J vaccine manufacturing error 'disappointing'bizjournals.com- MCongressional investigation initiated into Emergent BioSolutions’ vaccine contractsmvtelegraph.com
- Investor sues Emergent BioSolutions over demand for anthrax vaccinebizjournals.com
- BEmergent BioSolutions Faces Lawsuits Related to Vaccine Troubles3 min readbarrons.com
- Emergent BioSolutions calls J&J vaccine manufacturing error at Baltimore facility 'disappointing'bizjournals.com
FDA OK's Emergent BioSolutions plant to resume manufacturing J&J's Covid vaccineCNN
Emergent BioSolutions secures $90M COVID vaccine development, manufacturing agreement thedailyrecord.com- Emergent BioSolutions setbacks cause J&J vaccine supply to dwindlebizjournals.com
- Emergent BioSolutions to pause vaccine manufacturing at Baltimore facilitybizjournals.com
Emergent admits to manufacturing issues with J&J vaccinePOLITICO- Emergent BioSolutions cleared to resume Covid-19 vaccine manufacturing at Baltimore plantbizjournals.com
Emergent BioSolutions manufacturing Ebola treatment in Baltimorebaltimoresun.com
Committees’ report on emergent BioSolutions uncovers extensive vaccine manufacturing failures, clear efforts to hide deficienciesafro.com- What J&J’s Covid-19 vaccine situation means for Maryland’s Emergent BioSolutionsbizjournals.com
- Emergent BioSolutions to expand Mass. manufacturing workbizjournals.com
- Inside Emergent BioSolutions’ Covid-19 vaccine strategybizjournals.com
- FDA orders J&J contractor Emergent to stop vaccine production during inspectionPOLITICO
- J&J vaccine production could restart in U.S. 'within days,' Emergent executive testifiesPOLITICO